Samriddhi Shukla

Employment

• Cincinnati Children's Hospital Medical Center Research Associate
  2016 - Present
• Central Drug Research Institute Senior Research Fellow
  2011 - 2016

Education

• Central Drug Research Institute Doctor of Philosophy
  2011 - 2016
• Dr. Ram Manohar Lohia Avadh University Post Graduation
  2008 - 2010

Projects & Funding

Projects & funding information is unavailable.

Publications (22)

• FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.
  Oncogene 2021 DOI: 10.1038/s41388-021-01694-9
  +Save
• Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis
  Life Sciences 2020 DOI: 10.1016/j.lfs.2020.117976
  +Save
• FOXM1 nuclear transcription factor translocates into mitochondria and inhibits oxidative phosphorylation
  Molecular Biology of the Cell 2020 DOI: 10.1091/MBC.E19-07-0413
  +Save
• Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals
  Advances in Experimental Medicine and Biology 2019 DOI: 10.1007/978-3-030-20301-6_16
  +Save
• The FOXM1 inhibitor RCM-1 decreases carcinogenesis and nuclear b-catenin
  Molecular Cancer Therapeutics 2019 DOI: 10.1158/1535-7163.MCT-18-0709
  +Save
• Lung cancer stem cells: An epigenetic perspective
  Current Cancer Drug Targets 2018 DOI: 10.2174/1568009617666170206104623
  +Save
• Identification of potent inhibitors of DNA methyltransferase 1 (DNMT1) through a pharmacophore-based virtual screening approach
  Journal of Molecular Graphics and Modelling 2017 DOI: 10.1016/j.jmgm.2017.05.014
  +Save
• Centchroman altered the expressions of tumor-related genes through active chromatin modifications in mammary cancer
  Molecular Carcinogenesis 2016 DOI: 10.1002/mc.22424
  +Save
• Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis
  International Journal of Biochemistry and Cell Biology 2016 DOI: 10.1016/j.biocel.2016.05.014
  +Save
• Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis
  Scientific Reports 2016 DOI: 10.1038/srep21860
  +Save